Genomic Valley Biotech Ltd
company logo

Genomic Valley Biotech Ltd

GENOMICVALLEY Share Price

BSE:539206

28.8

1.35 (4.92%)

As on April 13, 2026 at 04:00 PM
Loading chart...

Performance

Loading performance...

27.45

27.45

1924

0.01

10

Fundamentals

8.80Cr

0

2.24

0

0

0%

12.85

About

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally. The Company is extensively involved in commercial greenhouse / poly house cultivation of crops. Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses, NFT & DFT etc, manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer. Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry. The Company identified a cluster of 700 marginal farmers eligible to form a Farmers Producer Company. It already started opening a training centre, imparting training to farmers and agri-entrepreneurs profitably. Separate courses have been designed for Training like the Ladies to develop kitchen gardens or small farms which can fetch them profits by growing fruits and vegetables. Apart from this, the Company is also providing Agri Farming Consultancy to farmers and other clients on case to case basis. In 2025, Company launched and optimized a dynamic website to serve as a hub for its services and values. It expanded the services to include advanced genomic pipelines like Whole Genome Sequencing, Exome Sequencing, Gut Microbiome Analysis, and Targeted Sequencing Panels. It started two groundbreaking projects: one exploring the genetic basis of Chronic Kidney Disease (CKD) and another combining genomics with Ayurveda in a Hair Follicle Growth Study. By building a comprehensive database and conducting in-depth market research, Company enhanced the understanding of healthcare trends, delivering solutions to the needs of patients and clinicians effectively.

1994

NameDesignation
YOGESH AGRAWALChairman / Executive Director / MD / CFO
Parul AgrawalNon-Exec & Non-Independent Dir
Satendra Kumar GoyalIndependent Non Exe. Director
Yogainder Kumar GuptaIndependent Non Exe. Director
Anupam AdityaCompany Sec. & Compli. Officer

Genomic Valley Biotech Ltd FAQs

How do I Buy Genomic Valley Biotech Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Genomic Valley Biotech Ltd shares in BlinkX.

What is the Share Price of Genomic Valley Biotech Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Genomic Valley Biotech Ltd's share price is ₹28.8 as of 2026-04-14.

What is the PE ratio of Genomic Valley Biotech Ltd?

close

Genomic Valley Biotech Ltd's P/E ratio is - times as of 2026-04-14.

What is the PB ratio of Genomic Valley Biotech Ltd?

close

Genomic Valley Biotech Ltd's most recent financial reports indicate a price-to-book ratio of 2.24, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Genomic Valley Biotech Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Genomic Valley Biotech Ltd's market capitalization is ₹8.8 Cr as on 2026-04-14.

What is the ROE of Genomic Valley Biotech Ltd?

close

The current financial records of Genomic Valley Biotech Ltd show a 9.69% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Genomic Valley Biotech Ltd?

close

According to Genomic Valley Biotech Ltd's most recent financial filings, the company has a total asset value of ₹2.62, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Genomic Valley Biotech Ltd?

close

The 52-week high/low price of a Genomic Valley Biotech Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Genomic Valley Biotech Ltd's 52-week high and low as of 2026-04-14 are ₹64 and ₹20.1, respectively.